Insights | VML

Insight

VML Health Patient Advocacy Summit

When Voices Connect, Change Happens

Insight

ESMO 2025: When discovery meets humanity

From landmark breakthroughs to moments of humanity, ESMO’s golden anniversary showed progress in oncology is powered not just by discovery, but by connection.

Read Article

Insight

Can Adland Finally Market the Unmarketable?

VML Health CEO Claire Gillis urges creatives to confront breast cancer’s toughest truth - make metastatic disease impossible to ignore this MBC Awareness Day.

Beyond the Bill: how do we make medicines affordable without killing innovation?

Exploring how to balance affordable, accessible medicines with sustaining pharmaceutical R&D, a critical challenge for healthcare.

Leading from the inside out: The transformation of Medical Affairs

From supporting act to strategic leader: Medical Affairs is driving launch readiness and patient outcomes in a rapidly evolving pharma landscape.

Read Article

Insight

The PBM Paradox: From Cost Containment to Price Spikes and What Comes Next

Unpacking the opaque world of PBM rebates and exploring actionable strategies for true reform and significant savings in prescription drug costs.

Read Article

Insight

Trends Report: Key Takeaways for Pharma from Cannes 2025

Cannes Lions 2025 moved beyond traditional functional messaging to embrace bold creativity and human (patient focused) approaches.

Read Article

Insight

ASCO 2025

Groundbreaking science, China's innovation, and the urgent need for collaborative, patient-centric cancer care.

Read Article

Insight

New Executive Orders signal major shake-up in drug pricing and market access

New EOs Tackle Drug Prices & 'Pill Penalty', Driving Transparency & Reshaping Pharma Market Access Strategies

Read Article

Insight

Health Futures 2025

VML Reveals the "Brand Paradox" Shaping the Future of Health in 2025

Read Article

Insight

Rethinking cancer, one story at a time

This World Cancer Day (and far beyond it), we’re embracing its theme – United by Unique – because no two cancer journeys are the same.

Read Article

Insight

All Change: Why 2025 Will Be a Big Year for Transformation in Health Communications

Buckle up, folks. 2025 is shaping up to be a year of transformation in health.

Read Article

Insight

High science, high tech, high hopes: what stood out at ASH 2024

From game-changing breakthroughs to emotive art, ASH 2024 served up the perfect blend of science, storytelling, and humanity.

Read Article

Insight

Generative AI: is health creative finally getting personal?

Generative AI is the hottest ticket in town right now, considered to be a gamechanger in the push for personalized marketing. But what’s happening in health?

Read Article

Insight

Is this year a better year to have breast cancer?

VML Health CEO Claire Gillis provides inspiration for improving outcomes against breast cancer through improved healthcare marketing communications.

A review of metastatic breast cancer in 2024

An encouraging year in the field of metastatic breast cancer (mBC), with promising developments that could shift the dial of patient care.

Read Article

Other Insights